Silver Spring, MD, United States of America

James J Mond

This inventor holds 38 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Immunotherapy Vaccines. Top assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Biosynexus, Inc., Adma Biologics, Inc.. Active years: 1996-2026.

USPTO Granted Patents = 38 (Patent Applications = 5)

% Patents Active = 65.8

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 467(Granted Patents)

Location History:

Potomac, MD (US) (1996 - 1999)
Jerusalem, IL (1999 - 2007)
Silver Springs, MD (US) (2009 - 2014)
Silver Spring, MD (US) (2002 - 2024)

Company Filing History:

10 out of 196

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 5 out of 5

Adma Biomanufacturing, LLC

patents

6. 1 out of 1

Henry Jackson Foundation

patent

7. 1 out of 2

Uniformed Services University of the Health Sciences, an Institution of Higher Learning Within the Department of Defense

patents

8. 1 out of 106

University of Sheffield

patents

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Immunotherapy

Vaccines

Oligodeoxynucleotide

Antimicrobial

Conjugate Vaccines

Bacterial Biofilms

Monoclonal Antibodies

Protein Complexes

Hyperimmune Globulin

Immunodeficiency

Antigenic Polypeptides

B Cell Activation

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612450 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2026-04-28),

2. 12473351 - Compositions and methods for the treatment of immunodeficiency (2025-11-18),

3. 11897943 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2024-02-13),

4. 11780906 - Compositions and methods for the treatment of immunodeficiency (2023-10-10),

5. 11339206 - Compositions and methods for the treatment of immunodeficiency (2022-05-24),

6. 11084870 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2021-08-10),

7. 10821173 - Multimeric fusion protein vaccine and immunotherapeutic (2020-11-03),

8. 10683343 - Compositions and methods for the treatment of immunodeficiency (2020-06-16),

9. 10259865 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2019-04-16),

10. 9969793 - Compositions and methods for the treatment of immunodeficiency (2018-05-15),

11. 9962436 - Multimeric fusion protein vaccine and immunotherapeutic (2018-05-08),

12. 9907844 - Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines (2018-03-06),

13. 9815886 - Compositions and methods for the treatment of immunodeficiency (2017-11-14),

14. 9714283 - Compositions and methods for the treatment of immunodeficiency (2017-07-25),

15. 9107906 - Compositions and methods for the treatment of immunodeficiency (2015-08-18),

Title: The Innovative Journey of James J Mond

Introduction: James J Mond, a distinguished inventor hailing from Silver Springs, MD (US), has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: James J Mond's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, James J Mond has a proven track record of developing innovative solutions that have garnered international recognition. His expertise lies in merging technology with healthcare to create impactful tools for professionals.

Collaborations: Throughout his career, James J Mond has collaborated with leading research institutions and universities to further his inventions. His partnerships have led to the successful development and commercialization of several patented technologies.

Conclusion: James J Mond's relentless pursuit of innovation and his passion for creating solutions that address real-world challenges have solidified his position as a trailblazer in the field of technology. His contributions continue to inspire the next generation of inventors and entrepreneurs.